$46.53
0.120.26%
In chiusura: Nov 20, 4:00 PM EST
$46.53
N/A
Post-mercato: Nov 20, 4:00 PM EST

Enliven Therapeutics (ELVN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-0.36 | $-0.46 | 21.7 % |
| Q2 | Aug 5, 2026 | $-0.49 | $-0.37 | -32.4 % |
| Q1 | May 7, 2026 | $-0.38 | $-0.42 | 9.52 % |
| Q4 | Mar 3, 2026 | $-0.48 | $-0.45 | -6.67 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q1 | May 7, 2026 | $0 | $10.00K | -100.0 % |
| Q4 | Mar 3, 2026 | $0 | $10.00K | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.46 | $-0.37 | $-0.42 | $-0.45 |
| Actual | $-0.36 | $-0.49 | $-0.38 | $-0.48 |
| Surprise | +21.7% | -32.4% | +9.52% | -6.67% |
| Revenue | ||||
| Estimate | — | — | $10000 | $10000 |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | -100.0% | -100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.44 | $-0.45 | $-0.49 | $-0.53 |
| Revenue | ||||
| Consensus | — | — | — | — |